Multi-Leu peptide (ML-peptide) triacetate is a potent inhibitor of PACE4 (Ki=22 nM). It functions by competitively binding to the active site of PACE4, mimicking its substrate sequence, thereby inhibiting its catalytic activity. This compound can be utilized to investigate the specific role of PACE4 in the progression of prostate cancer.
Target:
Autophagy
* VAT and and shipping costs not included. Errors and price changes excepted
